Medicare Enrolled

Dr. Kalpita Hatti, MD

Rheumatology · Shenandoah, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
129 VISION PARK BLVD STE 206, Shenandoah, TX 77384
2813158130
Registered in NPPES since 2009
NPI: 1528297462 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hatti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hatti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hatti

Dr. Kalpita Hatti is a rheumatology specialist in Shenandoah, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Hatti performed 2,087 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Hatti received a total of $11,129 from 30 pharmaceutical and/or device companies across 564 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hatti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 49% volume in TX $11,129 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,087
Medicare services
Top 49% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
1,321 $27 $133
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
161 $90 $264
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
137 $101 $337
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
128 $22 $73
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
88 $136 $356
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
54 $21 $57
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
51 $20 $50
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
42 $21 $75
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
38 $16 $67
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
35 $120 $422
New patient office visit, complex (60-74 min) 32 $142 $508
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.6% high complexity
69.4% medium
22.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,129
Total received (2018-2024)
Avg $1,590/year across 7 years
Top 31% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
564
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,425
2023
$2,768
2022
$2,256
2021
$1,653
2020
$766
2019
$658
2018
$602

Payments by company (2024)

UCB, Inc.
$453
Janssen Biotech, Inc.
$375
ABBVIE INC.
$302
Amgen Inc.
$254
Novartis Pharmaceuticals Corporation
$226
Lilly USA, LLC
$178
Radius Health, Inc.
$161
AstraZeneca Pharmaceuticals LP
$118
GlaxoSmithKline, LLC.
$105
PFIZER INC.
$75
E.R. Squibb & Sons, L.L.C.
$59
TerSera Therapeutics LLC
$49
Alexion Pharmaceuticals, Inc.
$33
Genentech USA, Inc.
$20
Fresenius Kabi USA, LLC
$18
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,991
Janssen Biotech, Inc.
$1,291
ABBVIE INC.
$1,233
UCB, Inc.
$878
AstraZeneca Pharmaceuticals LP
$723
Novartis Pharmaceuticals Corporation
$668
Lilly USA, LLC
$621
E.R. Squibb & Sons, L.L.C.
$461
GlaxoSmithKline, LLC.
$408
Radius Health, Inc.
$271
Genentech USA, Inc.
$262
PFIZER INC.
$217
Horizon Therapeutics plc
$196
AbbVie, Inc.
$178
TerSera Therapeutics LLC
$133
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
Regeneron Healthcare Solutions, Inc.
$103
AbbVie Inc.
$67
Organon LLC
$56
Alexion Pharmaceuticals, Inc.
$48
Celgene Corporation
$38
Flexion Therapeutics, Inc.
$26
Antares Pharma, Inc.
$24
Hikma Pharmaceuticals USA
$22
Fresenius Kabi USA, LLC
$18
Merck Sharp & Dohme Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Mallinckrodt Enterprises LLC
$16
Horizon Pharma plc
$13
Cumberland Pharmaceuticals, Inc.
$11
Top 3 companies account for 49.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · ENTYVIO · EVENITY · Enbrel · HADLIMA · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Mitigare · NUCALA · OFEV · ORENCIA · Otezla · Otrexup · PENNSAID · Prolia · Quzyttir · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Stimufend · TALTZ · TREMFYA · Tavneos · Tymlos · XELJANZ · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Shenandoah?
Compare rheumatologists in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
28
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hatti is a clinical cardiology specialist, with moderate Medicare volume, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hatti experienced with infliximab-abda biosimilar injection, 10 mg?
Based on Medicare claims data, Dr. Hatti performed 1,321 infliximab-abda biosimilar injection, 10 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hatti receive payments from pharmaceutical companies?
Yes. Dr. Hatti received a total of $11,129 from 30 companies across 564 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hatti's costs compare to other rheumatologists in Shenandoah?
Dr. Hatti's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hatti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →